Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
Baxter launched its Sigma Spectrum Safety Management System this week at the American Society of Health-System Pharmacists meeting. The infusion pump system consists of an analytics software and a suite of remote professional services for cyber-security monitoring.
The Deerfield, Ill.-based company said its Sigma Spectrum system was developed to minimize infusion pump programming risks, with features like direct integration with electronic medical record systems and automatically connecting infusion pumps to installed drug libraries. The safety management system includes an infusion analytics application, which creates infusion data analyses and graphical reporting to help identify pump programming errors. Read more
Abyrx said today it raised $10 million in a new equity financing round and expanded its exclusive, global license agreement with Bezwada Biomedical to include the development and production of Bezwada’s soft-tissue adhesive tech.
Funds in the $10 million round came from Canaan Partners, MedEdge, BB Biotech Ventures and members of the company’s executive team, with funds slated to support Abyrx’s bone putty products and to accelerate pipeline developments. Read more
Abiomed said today that it won an expanded indication from the FDA for its Impella CP heart pump for high-risk patients.
The Impella CP device, which won pre-market approval earlier this year for up to 4 hours of treating patients for cardiogenic shock after acute myocardial infarction or cardiac surgery, can now be used to for up to 6 hours during high-risk percutaneous coronary interventions, Danvers, Mass.-based Abiomed said. Read more
OrthoSpace said it has closed a $7 million round of equity financing, being joined by newly vested medtech giant Johnson & Johnson.
OrthoSpace produces the InSpace orthopedic biodegradable balloon system designed for minimally invasive rotator cuff repair procedures. Read more
Chinese anti-trust regulators dinged MDT for more than $17 million for price fixing with its cardiovascular and diabetes devices.
The ¥118.5 million fine levied by China’s National Development & Reform Commission on Medtronic (Shanghai) Management Co. stemmed from an investigation into the company’s dealings with local distributors. Medtronic sought to monopolize those markets by fixing prices and setting lower limits on resale prices to hospitals. Read more